379 related articles for article (PubMed ID: 34187859)
1. Association of Locus Coeruleus and Substantia Nigra Pathology With Cognitive and Motor Functions in Patients With Parkinson Disease.
Prasuhn J; Prasuhn M; Fellbrich A; Strautz R; Lemmer F; Dreischmeier S; Kasten M; Münte TF; Hanssen H; Heldmann M; Brüggemann N
Neurology; 2021 Sep; 97(10):e1007-e1016. PubMed ID: 34187859
[TBL] [Abstract][Full Text] [Related]
2. An investigation of neuromelanin distribution in substantia nigra and locus coeruleus in patients with Parkinson's disease using neuromelanin-sensitive MRI.
Liu Q; Wang P; Liu C; Xue F; Wang Q; Chen Y; Hou R; Chen T
BMC Neurol; 2023 Aug; 23(1):301. PubMed ID: 37580712
[TBL] [Abstract][Full Text] [Related]
3. Neuromelanin-sensitive magnetic resonance imaging features of the substantia nigra and locus coeruleus in de novo Parkinson's disease and its phenotypes.
Wang J; Li Y; Huang Z; Wan W; Zhang Y; Wang C; Cheng X; Ye F; Liu K; Fei G; Zeng M; Jin L
Eur J Neurol; 2018 Jul; 25(7):949-e73. PubMed ID: 29520900
[TBL] [Abstract][Full Text] [Related]
4. Mild cognitive impairment in de novo Parkinson's disease: A neuromelanin MRI study in locus coeruleus.
Li Y; Wang C; Wang J; Zhou Y; Ye F; Zhang Y; Cheng X; Huang Z; Liu K; Fei G; Zhong C; Zeng M; Jin L
Mov Disord; 2019 Jun; 34(6):884-892. PubMed ID: 30938892
[TBL] [Abstract][Full Text] [Related]
5. Neuromelanin related ultra-high field signal intensity of the locus coeruleus differs between Parkinson's disease and controls.
Wolters AF; Heijmans M; Priovoulos N; Jacobs HIL; Postma AA; Temel Y; Kuijf ML; Michielse S
Neuroimage Clin; 2023; 39():103479. PubMed ID: 37494758
[TBL] [Abstract][Full Text] [Related]
6. In vivo detection of substantia nigra and locus coeruleus volume loss in Parkinson's disease using neuromelanin-sensitive MRI: Replication in two cohorts.
Hwang KS; Langley J; Tripathi R; Hu XP; Huddleston DE
PLoS One; 2023; 18(4):e0282684. PubMed ID: 37053195
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous imaging of locus coeruleus and substantia nigra with a quantitative neuromelanin MRI approach.
Chen X; Huddleston DE; Langley J; Ahn S; Barnum CJ; Factor SA; Levey AI; Hu X
Magn Reson Imaging; 2014 Dec; 32(10):1301-6. PubMed ID: 25086330
[TBL] [Abstract][Full Text] [Related]
8. Substantia nigra neuromelanin magnetic resonance imaging in de novo Parkinson's disease patients.
Reimão S; Pita Lobo P; Neutel D; Correia Guedes L; Coelho M; Rosa MM; Ferreira J; Abreu D; Gonçalves N; Morgado C; Nunes RG; Campos J; Ferreira JJ
Eur J Neurol; 2015 Mar; 22(3):540-6. PubMed ID: 25534480
[TBL] [Abstract][Full Text] [Related]
9. Locus coeruleus and substantia nigra neuromelanin magnetic resonance imaging differentiates Parkinson's disease and essential tremor.
Wang X; Huang P; Haacke EM; Liu Y; Zhang Y; Jin Z; Li Y; Xu Q; Liu P; Chen S; He N; Yan F
Neuroimage Clin; 2023; 38():103420. PubMed ID: 37141646
[TBL] [Abstract][Full Text] [Related]
10. A distinct neuromelanin magnetic resonance imaging pattern in parkinsonian multiple system atrophy.
Simões RM; Castro Caldas A; Grilo J; Correia D; Guerreiro C; Pita Lobo P; Valadas A; Fabbri M; Correia Guedes L; Coelho M; Rosa MM; Ferreira JJ; Reimão S
BMC Neurol; 2020 Nov; 20(1):432. PubMed ID: 33243166
[TBL] [Abstract][Full Text] [Related]
11. Substantia Nigra Neuromelanin as an Imaging Biomarker of Disease Progression in Parkinson's Disease.
Fabbri M; Reimão S; Carvalho M; Nunes RG; Abreu D; Guedes LC; Bouça R; Lobo PP; Godinho C; Coelho M; Gonçalves NC; Rosa MM; Antonini A; Ferreira JJ
J Parkinsons Dis; 2017; 7(3):491-501. PubMed ID: 28671143
[TBL] [Abstract][Full Text] [Related]
12. Changes in substantia nigra and locus coeruleus in patients with early-stage Parkinson's disease using neuromelanin-sensitive MR imaging.
Ohtsuka C; Sasaki M; Konno K; Koide M; Kato K; Takahashi J; Takahashi S; Kudo K; Yamashita F; Terayama Y
Neurosci Lett; 2013 Apr; 541():93-8. PubMed ID: 23428505
[TBL] [Abstract][Full Text] [Related]
13. Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease.
Sasaki M; Shibata E; Tohyama K; Takahashi J; Otsuka K; Tsuchiya K; Takahashi S; Ehara S; Terayama Y; Sakai A
Neuroreport; 2006 Jul; 17(11):1215-8. PubMed ID: 16837857
[TBL] [Abstract][Full Text] [Related]
14. Spatiotemporal changes in substantia nigra neuromelanin content in Parkinson's disease.
Biondetti E; Gaurav R; Yahia-Cherif L; Mangone G; Pyatigorskaya N; Valabrègue R; Ewenczyk C; Hutchison M; François C; Arnulf I; Corvol JC; Vidailhet M; Lehéricy S
Brain; 2020 Sep; 143(9):2757-2770. PubMed ID: 32856056
[TBL] [Abstract][Full Text] [Related]
15. Neuromelanin magnetic resonance imaging of substantia nigra and locus coeruleus in Parkinson's disease with freezing of gait.
Wang S; Wu T; Cai Y; Yu Y; Chen X; Wang L
Front Aging Neurosci; 2023; 15():1060935. PubMed ID: 36819729
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal Changes in Neuromelanin MRI Signal in Parkinson's Disease: A Progression Marker.
Gaurav R; Yahia-Cherif L; Pyatigorskaya N; Mangone G; Biondetti E; Valabrègue R; Ewenczyk C; Hutchison RM; Cedarbaum JM; Corvol JC; Vidailhet M; Lehéricy S
Mov Disord; 2021 Jul; 36(7):1592-1602. PubMed ID: 33751655
[TBL] [Abstract][Full Text] [Related]
17. Reproducibility of locus coeruleus and substantia nigra imaging with neuromelanin sensitive MRI.
Langley J; Huddleston DE; Liu CJ; Hu X
MAGMA; 2017 Apr; 30(2):121-125. PubMed ID: 27687624
[TBL] [Abstract][Full Text] [Related]
18. Substantia nigra neuromelanin magnetic resonance imaging in patients with different subtypes of Parkinson disease.
Wang L; Yan Y; Zhang L; Liu Y; Luo R; Chang Y
J Neural Transm (Vienna); 2021 Feb; 128(2):171-179. PubMed ID: 33559725
[TBL] [Abstract][Full Text] [Related]
19. Multimodal Imaging of Substantia Nigra in Parkinson's Disease with Levodopa-Induced Dyskinesia.
Su D; Gan Y; Zhang Z; Cui Y; Zhang Z; Liu Z; Wang Z; Zhou J; Sossi V; Stoessl AJ; Wu T; Jing J; Feng T
Mov Disord; 2023 Apr; 38(4):616-625. PubMed ID: 36799459
[TBL] [Abstract][Full Text] [Related]
20. A Parkinson's disease patient displaying increased neuromelanin-sensitive areas in the substantia nigra after rehabilitation with tDCS: a case report.
Ishikuro K; Hattori N; Imanishi R; Furuya K; Nakata T; Dougu N; Yamamoto M; Konishi H; Nukui T; Hayashi T; Anada R; Matsuda N; Hirosawa H; Tanaka R; Shibata T; Mori K; Noguchi K; Kuroda S; Nakatsuji Y; Nishijo H
Neurocase; 2021 Oct; 27(5):407-414. PubMed ID: 34503372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
